Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
1.
Sleep Med Rev ; 69: 101770, 2023 06.
Article in English | MEDLINE | ID: mdl-36924608

ABSTRACT

This systematic review aims to assess the association between attention deficit hyperactivity disorder (ADHD) and restless legs syndrome (RLS) in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Databases were searched for original articles that reported prevalence data on ADHD and RLS until January 24th, 2023. Two independent reviewers evaluated the quality of the articles using the National Institutes of Health assessment tool. Among the 208 articles identified between 1996 and 2022, 29 were included. In large general population studies, 2.6-15.3% of participants met the RLS criteria, of which 3.2-17.4% presented with ADHD. In the ADHD group, RLS symptoms ranged from 11 to 42.9% in children and 20-33.0% in adults. This suggests a strong co-occurrence between RLS and ADHD. A common characteristic of these conditions is sleep fragmentation, as discussed in the reviewed papers. Although large-scale studies with comparable diagnostic criteria across the lifespan are required, our findings may advocate a possible common physiological pathway, including sleep fragmentation and dopaminergic system impairment.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Restless Legs Syndrome , Child , Adult , Humans , Restless Legs Syndrome/epidemiology , Restless Legs Syndrome/diagnosis , Attention Deficit Disorder with Hyperactivity/complications , Attention Deficit Disorder with Hyperactivity/epidemiology , Sleep Deprivation , Longevity , Dopamine
3.
J Endocrinol Invest ; 39(8): 923-31, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27023105

ABSTRACT

PURPOSE: To evaluate the effects of a continuous regimen combined oral contraceptive (COC) containing 2 mg dienogest and 30 µg ethinyl estradiol (DNG/EE) compared to a 21/7 regimen on the quality of life (QoL) and sexual function in women affected by endometriosis-associated pelvic pain. METHODS: Sixty-three women constituted the Study group treated with DNG/EE COC continuous regimen; 33 women were given DNG/EE COC in a 21/7 regimen. To define the endometriosis-associated pelvic pain, the Visual Analogic Scale was used. The Short Form-36, Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess QoL, sexual function and sexual distress, respectively. The study included two follow-ups. RESULTS: At 3 and 6 months of treatment there was an improvement in pain of the Study group (p < 0.001). The Control group underwent pain improvement at the second follow-up (p < 0.05). At the first and the second follow-ups, the Study group reported QoL improvements in all categories (p < 0.001). The Control group reported QoL improvements in all categories at the second follow-up (p < 0.05). At the first and the second follow-ups of the Study group, the FSFI total score had risen (p < 0.001), and the FSDS score had dropped (p < 0.001). An improvement of the FSFI score and a reduction of the FSDS score of the Control group was observed at the second follow-up (p < 0.001), but not at the first follow-up (p = NS). CONCLUSIONS: Women on DNG/EE COC continuous regimen reported a reduction of endometriosis-associated pelvic pain and there was an improvement of their sexual activity and their QoL that was better than the DNG/EE 21/7 conventional regimen.


Subject(s)
Contraceptives, Oral, Combined/therapeutic use , Endometriosis/complications , Ethinyl Estradiol/therapeutic use , Nandrolone/analogs & derivatives , Pelvic Pain/drug therapy , Quality of Life , Sexual Behavior/drug effects , Adolescent , Adult , Case-Control Studies , Estrogens/therapeutic use , Female , Follow-Up Studies , Humans , Nandrolone/therapeutic use , Pain Measurement , Pelvic Pain/etiology , Prognosis , Prospective Studies , Young Adult
4.
Minerva Ginecol ; 67(5): 413-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26491823

ABSTRACT

AIM: The aim of this paper was to evaluate the effects of the association between palmitoylethanolamide (PEA) and α-lipoic acid (LA) on quality of life (QoL) and sexual function in women affected by endometriosis-associated pelvic pain. METHODS: Fifty-six women constituted the study group and were given PEA 300 mg and LA 300mg twice daily To define the endometriosis-associated pelvic pain, the visual analogic scale (VAS) was used. The Short Form-36 (SF-36), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess the QoL, the sexual function and the sexual distress, respectively. The study included three follow-ups at 3, 6 and 9 months. RESULTS: No changes were observed in pain, QoL and sexual function at the 3rd month follow-up (P=NS). By the 6th and 9th month, pain symptoms (P<0.001) and all categories of the QoL (P<0.001) improved. The FSFI and the FSDS scores did not change at the 3rd month follow-up (P=ns). On the contrary, at the 3rd and 9th months follow-ups they improved with respect to the baseline (P<0.001). CONCLUSION: The progressive reduction of the pain syndrome reported by women over the treatment period could contribute to improve the QoL and sexual life of women on PEA and LA.


Subject(s)
Endometriosis/drug therapy , Ethanolamines/administration & dosage , Palmitic Acids/administration & dosage , Pelvic Pain/drug therapy , Thioctic Acid/administration & dosage , Adolescent , Adult , Amides , Chronic Pain/drug therapy , Chronic Pain/etiology , Drug Therapy, Combination , Endometriosis/complications , Ethanolamines/therapeutic use , Female , Follow-Up Studies , Humans , Pain Measurement , Palmitic Acids/therapeutic use , Pelvic Pain/etiology , Psychiatric Status Rating Scales , Quality of Life , Reproductive Health , Sexual Behavior , Sexual Dysfunction, Physiological/diagnosis , Sexual Dysfunctions, Psychological/diagnosis , Thioctic Acid/therapeutic use , Young Adult
5.
J Endocrinol Invest ; 38(11): 1211-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26337183

ABSTRACT

PURPOSE: The aim of the study was to evaluate the effects of dienogest (DNG) on quality of life (QoL) and sexual function of women affected by endometriosis pain. METHODS: Fifty-four women constituted the study group and were given 2 mg/daily DNG; 48 women were given non-steroidal anti-inflammatory drugs and constitut ed the control group. To define the endometriosis-associated pelvic pain, the Visual Analogic Scale (VAS) was used. The Short Form-36 (SF-36), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess the QoL, the sexual function and the sexual distress, respectively. The study included two follow-ups at 3 and 6 months. RESULTS: Pain improvement was observed in the study group at 3 (p < 0.05) and 6 months (p < 0.001) of treatment. At the 1st follow-up, women reported QoL improvements in some functions (p < 0.05); at the 2nd follow-up, they reported improvement in all categories (p < 0.001). The FSFI score did not change at the 1st follow-up (p = NS). On the contrary, at the 2nd follow-up, it improved with respect to the baseline (p < 0.05). At the 2nd follow-up, the FSFI score had risen to 27.8 (p < 0.001) and the FSDS score had dropped to 11.3 (p < 0.001). No change was observed in the control group (p = NS). CONCLUSIONS: The progressive reduction of the pain syndrome reported by women over the treatment period could contribute to improve the QoL and sexual life of women on DNG.


Subject(s)
Hormone Antagonists/pharmacology , Nandrolone/analogs & derivatives , Orgasm/drug effects , Pelvic Pain/drug therapy , Quality of Life , Sexual Behavior/drug effects , Adolescent , Adult , Endometriosis/complications , Female , Follow-Up Studies , Hormone Antagonists/administration & dosage , Humans , Nandrolone/administration & dosage , Nandrolone/pharmacology , Pelvic Pain/etiology , Treatment Outcome , Young Adult
6.
Bioresour Technol ; 101(21): 8132-43, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20624602

ABSTRACT

Biomass from lignocellulosic energy crops can contribute to primary energy supply in the short term in heat and electricity applications and in the longer term in transport fuel applications. This paper estimates the optimal feedstock allocation of herbaceous and woody lignocellulosic energy crops for England and Wales based on empirical productivity models. Yield maps for Miscanthus, willow and poplar, constrained by climatic, soil and land use factors, are used to estimate the potential resource. An energy crop supply-cost curve is estimated based on the resource distribution and associated production costs. The spatial resource model is then used to inform the supply of biomass to geographically distributed demand centres, with co-firing plants used as an illustration. Finally, the potential contribution of energy crops to UK primary energy and renewable energy targets is discussed.


Subject(s)
Agriculture , Bioelectric Energy Sources/supply & distribution , Crops, Agricultural/growth & development , Models, Biological , Poaceae/growth & development , Agriculture/economics , Bioelectric Energy Sources/economics , Biomass , Crops, Agricultural/economics , Lignin/metabolism , Resource Allocation , United Kingdom
7.
New Phytol ; 178(2): 358-370, 2008.
Article in English | MEDLINE | ID: mdl-18331429

ABSTRACT

Limited information on likely supply and spatial yield of bioenergy crops exists for the UK. Here, productivities are reported of poplar (Populus spp.) and willow (Salix spp.) grown as short-rotation coppice (SRC), using data from a large 49-site yield trial network. A partial least-squares regression technique was used to upscale actual field trial observations across England and Wales. Spatial productivity was then assessed under different land-use scenarios. Mean modelled yields ranged between 4.9 and 10.7 oven-dry tonnes (odt) ha(-1) yr(-1). Yields were generally higher in willow than in poplar, reflecting the susceptibility of older poplar genotypes to rust and their tendency for single stem dominance. Replacing 10% of arable land, 20% of improved grassland and 100% of set-aside grassland in England and Wales with the three most productive genotypes would yield 13 Modt of biomass annually (supplying 7% of UK electricity production or 48% of UK combined heat and power (CHP) production). Results show existing SRC genotypes have the immediate potential to be an important component of a mixed portfolio of renewables and that, in future, as new and improved genotypes become available, higher yields could extend this potential further.


Subject(s)
Conservation of Energy Resources , Populus/growth & development , Salix/growth & development , Agriculture , Models, Biological , Populus/genetics , Salix/genetics , United Kingdom
8.
Tree Physiol ; 22(18): 1277-88, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12490425

ABSTRACT

Spatial distributions of leaf characteristics relevant to photosynthesis were compared within high-density coppice canopies of Populus spp. of contrasting genetic origin. We studied three clones representative of the range in growth potential, leaf morphology, coppice and canopy structure: Clone Hoogvorst (Hoo) (Populus trichocarpa Torr. & Gray x Populus deltoides Bartr. & Marsh), Clone Fritzi Pauley (Fri) (Populus trichocarpa Torr. & Gray) and Clone Wolterson (Wol) (Populus nigra L.). Leaf area index ranged from 2.7 (Fri and Wol) to 3.8 (Hoo). The clones exhibited large vertical variation in leaf area density (0.02-1.42 m2 m-3). Leaf dry mass per unit leaf area (DM(A)) increased with increasing light in Clones Hoo and Fri, from about 56 g m-2 at the bottom of the canopy to 162 g m-2 at the top. In Clone Wol, DM(A) varied only from 65 to 100 g m-2, with no consistent relationship with respect to light. Conversely, nitrogen concentration on a mass basis was nearly constant (around 1.3-2.1%) within the canopies of Clones Hoo and Fri, but increased strongly with light in Clone Wol, from 1.4% at the bottom of the canopy to 4.1% at the top. As a result, nitrogen per unit leaf area (N(A)) increased with light in the canopies of all clones, from 0.9 g m-2 at the bottom to 2.9 g m-2 at the top. Although a single linear relationship described the dependence of maximum carboxylation rate (17-93 micromol CO2 m-2 s-1) or electron transport capacity (45-186 micromol electrons m-2 s-1) on N(A), for all clones, Clone Wol differed from Clones Hoo and Fri by exhibiting a higher dark respiration rate at low N(A) (1.8 versus 0.8 micromol CO2 m-2 s-1).


Subject(s)
Plant Leaves/physiology , Populus/physiology , Trees/physiology , Carbon/analysis , Carbon Dioxide/physiology , Nitrogen/analysis , Photosynthesis/physiology , Plant Leaves/anatomy & histology , Plant Leaves/chemistry , Populus/anatomy & histology , Sunlight , Trees/anatomy & histology
11.
Rev Hosp Clin Fac Med Sao Paulo ; 55(3): 101-4, 2000.
Article in English | MEDLINE | ID: mdl-10983013

ABSTRACT

Poliomyelitis associated with live strain vaccine is defined as the paralytic form of the acute anterior poliomyelitis related to the vaccine strain. Since these strains behave similarly to the wild-type virus, we can differentiate, epidemiologically, two types of vaccine-associated poliomyelitis: cases in which the patient was vaccinated and cases in which the patient had had contact with vaccinated individuals. We herein present the case of an unvaccinated child, with a clinical picture of an acute anterior poliomyelitis associated with the live strain vaccine, whose brother received the Sabin vaccine 20 days before the onset of the symptoms. Vaccine strain of the type 3 poliovirus was isolated in fecal culture and a presented mutation in nucleotide 472 (C-->U) in the 5' non-coding region, which is strongly related to the higher strain virulence.


Subject(s)
Disease Transmission, Infectious , Poliomyelitis/transmission , Poliovirus Vaccine, Oral/adverse effects , Child, Preschool , Feces/virology , Humans , Infant , Male , Poliomyelitis/cerebrospinal fluid , Poliomyelitis/diagnosis , Poliovirus/isolation & purification , Poliovirus Vaccine, Oral/administration & dosage
13.
Blood ; 93(9): 2959-67, 1999 May 01.
Article in English | MEDLINE | ID: mdl-10216091

ABSTRACT

The human platelet alloantigen 1 system (HPA-1) is determined by a polymorphism at position 33 in the N-terminus of human glycoprotein IIIa (GPIIIa). This naturally occurring substitution creates a conformation in the HPA-1a allelic form that can be antigenic when presented to an individual expressing the HPA-1b form. Anti-HPA-1a antibodies generated by this immune response can lead to the destruction of platelets, as seen in the clinical disorders, neonatal alloimmune thrombocytopenia (NAIT) and posttransfusion purpura (PTP). To understand better the structural requirements for recognition by these pathogenic antibodies, we investigated the N-terminal 66 amino acids from the HPA-1a form of human GPIIIa and the analogous amino acids from the nonimmunogenic murine homolog. Our objectives were to define further the boundaries of the HPA-1a epitope(s) in the N-terminus of human GPIIIa, to isolate the murine 5' nucleotide sequence and compare the deduced murine N-terminal sequence to that of human, and to mutate the murine sequence systematically to include an HPA-1a epitope(s). Murine amino acids that differed from human were changed by site-directed mutagenesis to the analogous residues in the HPA-1a form of human GPIIIa, starting and radiating from murine position 33 (site of human polymorphism). This systematic approach allowed us to pinpoint amino acids critical to a conformation recognized by anti-HPA-1a antibodies. Our results show that an HPA-1a epitope can be created within the N-terminus of murine GPIIIa and raise the possibility that murine models of HPA-1a sensitization can be developed.


Subject(s)
Antigens, Human Platelet/chemistry , Antigens, Human Platelet/immunology , Epitopes/chemistry , Platelet Glycoprotein GPIIb-IIIa Complex/chemistry , Platelet Glycoprotein GPIIb-IIIa Complex/immunology , Amino Acid Sequence , Amino Acid Substitution , Animals , Antibodies, Monoclonal , Binding Sites, Antibody , Binding, Competitive , Humans , Integrin beta3 , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Mutagenesis, Site-Directed , Platelet Glycoprotein GPIIb-IIIa Complex/genetics , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Sequence Alignment , Sequence Deletion , Sequence Homology, Amino Acid
14.
Arq Neuropsiquiatr ; 57(3B): 808-12, 1999 Sep.
Article in Portuguese | MEDLINE | ID: mdl-10751916

ABSTRACT

Hearing loss is the more frequent sequel of bacterial meningitis in children. This study describes the audiological profile (peripheric and central) of 89 children admitted to the hospital wards with the diagnosis of bacterial meningitis. Those children attended audiological follow up, after their hospital discharge, and were submitted to audiological tests. The results showed that 85.4% among them presented normal hearing in both ears 10.1% presented bilateral neurosensorial hearing loss and 4.5% presented unilateral neurosensorial hearing loss. The results from the auditory processing skills assessment showed that 10% of those children presented auditory localization and recognition of sentences with competitive messages (Paediatric Sentences Identification-ipsilateral) disorders.


Subject(s)
Hearing Loss, Bilateral/microbiology , Hearing Loss, Sensorineural/microbiology , Meningitis, Bacterial/complications , Child , Child, Preschool , Female , Follow-Up Studies , Hearing Loss, Bilateral/diagnosis , Hearing Loss, Sensorineural/diagnosis , Hearing Tests , Humans , Infant , Infant, Newborn , Male
15.
J Pediatr (Rio J) ; 75 Suppl 2: S197-206, 1999 Nov.
Article in Portuguese | MEDLINE | ID: mdl-14685466

ABSTRACT

OBJECTIVE: The authors make an up-to-date review about diagnosis and treatment of the acute seizures and status epilepticus.METHODS: Bibliographic review of Medline database including articles published in the last ten years.RESULTS: Acute seizures and status epilepticus affect children of all the age groups. Acute seizures can either represent the first manifestation of an epileptic condition or be an acute symptomatic event. Status epilepticus represents a serious cerebral insult determined by various causes. The emergency, neurology and pediatric intensive care units should elaborate clinical policy for the establishment of precise diagnostic criteria and therapeutic approach. A good clinical approach should include immediate life support, monitoring and rational drug administration to end up the seizure and reduce morbidity and mortality risks.CONCLUSION: The better understanding of the pathophysiology as well as the elaboration of a rational clinical policy improved the outcome in these medical emergencies.

16.
Arq Neuropsiquiatr ; 56(3B): 545-52, 1998 Sep.
Article in Portuguese | MEDLINE | ID: mdl-9850748

ABSTRACT

We report six patients with glutaric aciduria type 1 in four families. The patients had marked clinical variability, even within families. Three of the patients studied were normal until the onset of neurologic abnormalities, that presented as an encephalitis-like illness in the first year of age. One patient had an early and important developmental delay, but never suffered an encephalopathic crisis. Two patients have intellectual preservation; one of them has a mild tremor and choreoathetosis since the first year of age, and the other had only two afebrile seizures in infancy and no other neurologic signs. Three patients are severely handicapped, with a severe dystonic-dyskinetic disorder and unable to even sit. All the six patients have macrocephaly and in all the computed tomography showed enlarged CSF spaces and sulcal separation over the frontal and temporal lobes. Urine organic acids study of all patients showed large quantities of glutaric acid.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Amino Acids, Essential/metabolism , Glutarates/urine , Adult , Amino Acid Metabolism, Inborn Errors/diet therapy , Amino Acid Metabolism, Inborn Errors/genetics , Child , Child, Preschool , Female , Humans , Male , Phenotype
17.
Arq Neuropsiquiatr ; 56(3A): 472-5, 1998 Sep.
Article in Portuguese | MEDLINE | ID: mdl-9754431

ABSTRACT

We report a patient that presented two episodes of coma in the neonatal period, with severe metabolic acidosis and hypoglycemia, without ketosis. The urinary organic acid analysis showed increased amounts of 3-hydroxy-3-methyl-glutaric, 3-methylglutaconic, 3-methylglutaric and 3-hydroxyisovaleric acid. The deficiency of 3-hydroxy-3-methylglutaryl-CoA lyase was diagnosed by the clinical and metabolic features. This disease shows autosomal recessive inheritance and the treatment is done by a diet with restriction of protein (mainly leucine) and lipids, high in carbohydrate content, and the avoidance of fasting and carnitine supplementation.


Subject(s)
Coma/etiology , Metabolism, Inborn Errors/complications , Metabolism, Inborn Errors/diagnosis , Oxo-Acid-Lyases/deficiency , Humans , Infant, Newborn , Leucine/metabolism , Male , Metabolism, Inborn Errors/diet therapy , Metabolism, Inborn Errors/genetics
18.
Tissue Antigens ; 51(2): 156-63, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9510371

ABSTRACT

The human platelet alloantigen HPA-1a (PlA1) is responsible for most cases of post-transfusion purpura and neonatal alloimmune thrombocytopenia in the Caucasian population. HPA-1a and HPA-1b are two allelic forms of the platelet membrane glycoprotein IIIa (GPIIIa) gene that differ by a single amino acid. In this report, we describe the development of a recombinant heavy chain antibody fragment capable of distinguishing between the homozygous forms of HPA-1a and HPA-1b. This antibody fragment was isolated from the lymphocytes of an immunized individual through the use of a phage display library system. The recombinant antibody fragment reacted with human platelet lysates from HPA-1a homozygous donors, the HPA-1a form of recombinant N-terminal GPIIIa and intact HPA-1a platelets, but did not react with platelet lysate from HPA-1b homozygous donors, reduced HPA-1a form of platelet GPIIIa or other platelet glycoproteins. This HPA-1a specific human antibody fragment works well in common laboratory assays such as ELISA and flow cytometry, which can assist in identifying HPA-1b homozygous individuals who are known to have a higher risk for developing neonatal alloimmmune thrombocytopenia and post-transfusion purpura. Thus, selection of recombinant antibody fragment using phage display offers a promising alternative to hybridoma technology for the production of human antibodies against human alloantigens and holds potential as a technique in therapeutic applications.


Subject(s)
Antigens, Human Platelet , Immunoglobulin Fragments/genetics , Immunoglobulin Heavy Chains/genetics , Isoantigens , Antibody Specificity , Bacteriophage M13/genetics , Base Sequence , DNA Primers/genetics , Escherichia coli/genetics , Gene Library , Humans , Integrin beta3 , Isoantibodies/genetics , Molecular Sequence Data , Polymerase Chain Reaction , Recombinant Proteins/genetics , Recombinant Proteins/immunology
19.
J Pediatr (Rio J) ; 74(4): 306-14, 1998.
Article in Portuguese | MEDLINE | ID: mdl-14685612

ABSTRACT

OBJECTIVE: To evaluate the efficacy of dexamethasone as an auxiliary therapeutic tool to the antibiotics in hospitalized children with meningococcal meningitis. METHODS: A retrospective clinical comparative study was undertaken with children from a pediatric ward affected by laboratory proved meningococcal meningitis at a university hospital. Cases of children in state of shock at admission or deceased in the first 24 hours were excluded. During the period from 1987 to 1989 33 children were treated only with antibiotics (group A), while from 1990 to 1993 other 66 children received additionally dexamethasone (12mg/m2/24h) by intravenous route during four days beginning at the admission to the hospital (group B). The two groups were evaluated at baseline through prognostic scores and analysis of their clinical and laboratorial characteristics obtained from data recorded at the admission. The parameters to evaluate dexamethasone efficacy were the comparative number of neurologic and systemic complications detected at the hospital, and the liquoric profile (leukocyte count, glucose and protein content) verified between day 9 and day 11 of hospitalization. RESULTS: The profile of the two groups (A and B) were homogeneously evaluated by the illness severity scores and their clinical and laboratorial characteristics. Nine complications were recognized in group A (27.2%) and 21 (31.8%) among those of group B, difference not significant. Likewise, there were not observed liquoric differences between the two groups related to the chimiocytologic pattern. CONCLUSIONS: No effect of dexamethasone therapy to prevent neurologic and systemic meningococcal meningitis complications was observed during hospitalization. Similarly no favorable effect in relation to the liquoric pattern verified between day 9 and day 11 of hospitalization was recognized.

20.
Arq Neuropsiquiatr ; 55(2): 334-8, 1997 Jun.
Article in Portuguese | MEDLINE | ID: mdl-9629398

ABSTRACT

Bacterial meningitis is the main cause for acquired hearing loss. Nevertheless very little has been written about the development of the auditory behaviour either for improvement or for deterioration, after hospital release. The present study describes the case of a five month old boy with Haemophilus influenzae meningitis. Amongst various complications, a decrement in the auditory acuity was detected in the immediate evolution, with significant improvement later on by qualitative and quantitative tests.


Subject(s)
Hearing Disorders/etiology , Meningitis, Bacterial/complications , Humans , Infant , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...